Cargando…

Could pentraxin-3 be a new marker for subclinical inflammation in familial Mediterranean fever?

Detalles Bibliográficos
Autores principales:	Yüksel, S, Karadağlı, E, Evrengül, H, Şenol, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599666/ http://dx.doi.org/10.1186/1546-0096-13-S1-P98

Ejemplares similares

Quality of life in children with familial Mediterranean fever
por: Öztürk, Ö, et al.
Publicado: (2015)

Risk factors for subclinical inflammation in children with familial mediterranean fever
por: Soylu, Alper, et al.
Publicado: (2014)

Simple Markers for Subclinical Inflammation in Patients with Familial Mediterranean Fever
por: Özer, Samet, et al.
Publicado: (2015)

Familial Mediterranean Fever in older children
por: Özdel, Semanur, et al.
Publicado: (2014)

The role of genotype in Familial Mediterranean Fever
por: Özdel, Semanur, et al.
Publicado: (2014)

Comorbidities in patients with Familial Mediterranean Fever
por: Balci-Peynircioğlu, B, et al.
Publicado: (2015)

Neonatal onset Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)
por: Wittkowski, H, et al.
Publicado: (2008)

Chronic myelomonocytic leukemia as a cause of fatal uncontrolled inflammation in familial Mediterranean fever
por: Awad, F, et al.
Publicado: (2015)

The association of Familial Mediterranean Fever and cryptogenic cirrhosis
por: Baskin, E, et al.
Publicado: (2008)

Musculoskeletal complaints in patients with Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Familial Mediterranean Fever associated diseases in children
por: Özçakar, ZB, et al.
Publicado: (2015)

Articular involvement in childhood Familial Mediterranean Fever
por: Barut, K, et al.
Publicado: (2015)

Familial Mediterranean Fever and Human autoinflammatory diseases
por: Hovhannisyan, L
Publicado: (2015)

Challenging case of Familial Mediterranean Fever and its management
por: Al Hosani, A, et al.
Publicado: (2015)

Calprotectin (S100A8/A9) in Familial Mediterranean Fever
por: Pepper, R, et al.
Publicado: (2015)

Chronic recurrent multifocal osteomyelitis in a patient with Familial Mediterranean Fever
por: Daia, A, et al.
Publicado: (2015)

Pentraxin 3 as a marker of vasospasm following subarachnoid hemorrhage
por: Zanier, ER, et al.
Publicado: (2008)

Magnetic resonance imaging features of Familial Mediterranean Fever associated spondyloarthritis
por: Turan, A, et al.
Publicado: (2015)

LPS-induced gene expression of inflammation-related genes in neutrophils from familial Mediterranean fever patients
por: Manukyan, Gayane, et al.
Publicado: (2012)

Increased frequency of psoriasis in the families of subjects with childhood Familial Mediterranean Fever
por: Barut, Kenan, et al.
Publicado: (2014)

Anakinra treatment in patients with Familial Mediterranean Fever: a single-center experience
por: Ugurlu, S, et al.
Publicado: (2015)

Can Calprotectin Show Subclinical Inflammation in Familial Mediterranean Fever Patients?
por: Asan, Gökmen, et al.
Publicado: (2020)

Our successful surgical coronary revascularization in a case with familial Mediterranean fever
por: Yetkin, U, et al.
Publicado: (2013)

Is Familial Mediterranean Fever a clinical diagnosis? Results of a field survey
por: Ozdogan, H, et al.
Publicado: (2015)

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

Evidence based recommendations for genetic diagnosis of Familial Mediterranean Fever
por: Giancane, Gabriella, et al.
Publicado: (2014)

Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

L-ficolin and H-ficolin in patients with Familial Mediterranean fever
por: Mkrtchyan, G, et al.
Publicado: (2015)

PReS-FINAL-2214: Validation of new pediatric criteria in diagnosis of Familial Mediterranean Fever in children
por: Baskin, E, et al.
Publicado: (2013)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

PReS-FINAL-2215: Genotype-phenotype correlations in children with Familial Mediterranean Fever in Germany
por: Gohar, F, et al.
Publicado: (2013)

Underlying causes of persistently elevated acute phase reactants in patiens with Familial Mediterranean Fever
por: Mercan, R, et al.
Publicado: (2015)

Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF)
por: Vitale, A, et al.
Publicado: (2008)

Clinical and demographic characteristics of children with familial mediterranean fever in Central Anatolia
por: Akin, Onur, et al.
Publicado: (2011)

PReS-FINAL-2242: Familial Mediterranean Fever - first experiences in Slovakia
por: Dallos, T, et al.
Publicado: (2013)

Indications and efficacy of canakinumab in Familial Mediterranean Fever: report of three cases
por: Tsinti, Maria, et al.
Publicado: (2014)

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

Evaluation of familial mediterranean fever patients: a single center experience
por: Gulez, P, et al.
Publicado: (2015)

Adrenomedullin levels in patients with Familial Mediterranean Fever: a long term follow-up
por: Polat, A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bbghvfek4m4k721ngolt0jt8lc